Brighton Jones LLC Invests $1.41 Million in Veeva Systems Inc. $VEEV

Brighton Jones LLC bought a new position in Veeva Systems Inc. (NYSE:VEEVFree Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 4,880 shares of the technology company’s stock, valued at approximately $1,405,000.

Several other institutional investors and hedge funds also recently modified their holdings of VEEV. Nuveen LLC purchased a new stake in shares of Veeva Systems in the first quarter worth about $365,684,000. Price T Rowe Associates Inc. MD boosted its position in shares of Veeva Systems by 20.9% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,992,372 shares of the technology company’s stock worth $924,754,000 after buying an additional 689,700 shares during the period. Linonia Partnership LP boosted its position in shares of Veeva Systems by 52.7% in the first quarter. Linonia Partnership LP now owns 1,836,557 shares of the technology company’s stock worth $425,402,000 after buying an additional 633,585 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Veeva Systems by 48.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,799,931 shares of the technology company’s stock worth $416,918,000 after buying an additional 585,785 shares during the period. Finally, Alliancebernstein L.P. boosted its holdings in Veeva Systems by 10.7% in the first quarter. Alliancebernstein L.P. now owns 5,499,651 shares of the technology company’s stock valued at $1,273,884,000 after purchasing an additional 532,269 shares during the last quarter. Hedge funds and other institutional investors own 88.20% of the company’s stock.

Veeva Systems Stock Up 0.9%

NYSE:VEEV opened at $295.64 on Tuesday. The business’s 50 day moving average is $284.95 and its two-hundred day moving average is $270.59. Veeva Systems Inc. has a 52 week low of $201.54 and a 52 week high of $310.50. The company has a market cap of $48.46 billion, a PE ratio of 60.71, a P/E/G ratio of 2.26 and a beta of 0.98.

Veeva Systems (NYSE:VEEVGet Free Report) last released its earnings results on Wednesday, August 27th. The technology company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.90 by ($0.64). Veeva Systems had a return on equity of 13.72% and a net margin of 27.29%.The firm had revenue of $789.08 million for the quarter, compared to the consensus estimate of $768.49 million. During the same period in the prior year, the business earned $1.62 EPS. The company’s quarterly revenue was up 16.7% on a year-over-year basis. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. As a group, sell-side analysts expect that Veeva Systems Inc. will post 4.35 EPS for the current fiscal year.

Wall Street Analyst Weigh In

VEEV has been the subject of a number of analyst reports. Truist Financial increased their price target on Veeva Systems from $268.00 to $275.00 and gave the company a “hold” rating in a report on Thursday, August 28th. Canaccord Genuity Group increased their price target on Veeva Systems from $270.00 to $300.00 and gave the company a “hold” rating in a report on Thursday, August 28th. UBS Group increased their price target on Veeva Systems from $285.00 to $310.00 and gave the company a “neutral” rating in a report on Thursday, August 28th. JPMorgan Chase & Co. raised Veeva Systems from a “neutral” rating to an “overweight” rating and increased their price target for the company from $290.00 to $330.00 in a report on Monday, September 8th. Finally, TD Cowen raised Veeva Systems from a “hold” rating to a “buy” rating and increased their price target for the company from $297.00 to $380.00 in a report on Tuesday, October 7th. Seventeen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $307.58.

Get Our Latest Analysis on Veeva Systems

Insider Transactions at Veeva Systems

In other news, insider Thomas D. Schwenger sold 3,350 shares of the stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $300.04, for a total transaction of $1,005,134.00. Following the sale, the insider directly owned 23,773 shares in the company, valued at approximately $7,132,850.92. This represents a 12.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Jonathan Faddis sold 720 shares of the stock in a transaction that occurred on Monday, October 6th. The stock was sold at an average price of $298.12, for a total value of $214,646.40. Following the sale, the senior vice president owned 7,868 shares in the company, valued at $2,345,608.16. The trade was a 8.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 24,665 shares of company stock worth $7,438,000. 10.30% of the stock is currently owned by company insiders.

Veeva Systems Company Profile

(Free Report)

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

Further Reading

Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEVFree Report).

Institutional Ownership by Quarter for Veeva Systems (NYSE:VEEV)

Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.